ArticleMedicine2021

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.

Assaf Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.